z-logo
open-access-imgOpen Access
Does furosemide prevent renal dysfunction in high-risk cardiac surgical patients? Results of a double-blinded prospective randomised trial☆☆☆
Author(s) -
Balakrishnan Mahesh,
Boyd Yim,
D. Robson,
Ravi Pillai,
Chandana Ratnatunga,
David C. Pigott
Publication year - 2008
Publication title -
european journal of cardio-thoracic surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.303
H-Index - 133
eISSN - 1873-734X
pISSN - 1010-7940
DOI - 10.1016/j.ejcts.2007.12.030
Subject(s) - furosemide , medicine , creatinine , renal function , ejection fraction , cardiopulmonary bypass , placebo , urology , anesthesia , diabetes mellitus , surgery , heart failure , endocrinology , alternative medicine , pathology
Renal dysfunction following cardiac surgery is more apparent in high-risk patients with pre-existing renal dysfunction, diabetes and impaired left-ventricular function, and following complicated procedures involving prolonged cardiopulmonary bypass (CPB). The aim of this prospectively randomised double-blinded placebo-controlled study was to evaluate reno-protective effect of low-dose furosemide infusion in this high-risk group.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom